Electrocardiogram signal processing method and apparatus, and related device

MYPI2025003100A0Undetermined Publication Date: 2024-05-21BISHENGPU BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003100
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-11-21
Filing Date
2023-05-11
Publication Date
2024-05-21

AI Technical Summary

Technical Problem

Traditional methods are time-consuming and inaccurate in heart failure risk assessment, and cannot effectively monitor the risk of myocardial infarction, heart failure and other diseases in young people.

Method used

By acquiring the ECG signals of the leads, extracting the static high-frequency QRS waveform feature set and the dynamic high-frequency QRS waveform feature set under resting and stress conditions, combined with the preset risk assessment function or network model, the heart failure risk assessment score is calculated To determine the risk of heart failure.

Benefits of technology

It significantly reduces the time required for heart failure risk assessment, improves the accuracy and efficiency of assessment, enables earlier detection of heart failure risk, and is suitable for young people.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PI2025003100_DRAWING_001
    Figure PI2025003100_DRAWING_001
  • Figure PI2025003100_DRAWING_002
    Figure PI2025003100_DRAWING_002
  • Figure PI2025003100_DRAWING_003
    Figure PI2025003100_DRAWING_003
Patent Text Reader

Abstract

The present application relates to an electrocardiogram signal processing method and apparatus, and a related device. The method comprises: acquiring electrocardiosignals of a first preset number of leads in a resting state, the leads comprising a second preset number of limb leads, and the second preset number being smallerthan the first preset number;performing data processing on each electrocardiosignal in the resting state so as to obtain a static high-frequency QRS waveform feature set, the static high-frequency QRS waveform feature set comprising a QRS time limit, thenumber of first positive indexes, the number of first target leads and the number of target limb leads; and performing assessment and analysis on a risk assessment feature set so as to obtain a heart failure risk assessment score, the heart failure risk assessment score being used for judging the risk level of developing heart failure,and the risk assessment feature set comprising said static high-frequency QRS waveform feature set.
Need to check novelty before this filing date? Find Prior Art

Description

Electrocardiogram signal processing method, device and related equipment

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to a Chinese patent application filed with the Patent Office of China on November 21, 2022, with application number 2022114516528 and application name “Electrocardiogram Signal Processing Method, Device and Related Equipment,” the entire contents of which are incorporated herein by reference. Technical Field

[0003] The present application relates to the technical field of electrocardiogram (ECG) signal processing, and in particular to an ECG signal processing method, apparatus, computer equipment, and storage medium. Background Art

[0004] With the improvement of social and economic development, people's living standards are also improving year by year. More and more people are transitioning from physical labor to mental labor, which makes people's average exercise time decrease year by year. Many diseases that used to belong to the elderly are gradually appearing more and more in young people, such as myocardial infarction, heart failure, etc.

[0005] Traditionally, heart failure risk assessment is often performed using a combination of blood tests for N-terminal pro-B-type natriuretic peptide (NT-proBNP), plasma homocysteine, and echocardiographic measurements of left ventricular ejection fraction (LVEF), left ventricular end-systolic dimension (LVESD), and a 6-minute walk test. However, these traditional methods are time-consuming and inaccurate. Summary of the Invention

[0006] According to various embodiments disclosed in this application, a method, apparatus, and related equipment for processing electrocardiogram signals are provided.

[0007] In a first aspect, a method for processing an electrocardiogram signal is provided, comprising:

[0008] Acquiring a first preset number of leads of electrocardiographic signals in a resting state; the leads include a second preset number of limb leads; the second preset number is less than the first preset number;

[0009] Data processing is performed on the ECG signals in each resting state to obtain a static high-frequency QRS waveform feature set; wherein the static high-frequency QRS waveform feature set includes the QRS duration, the number of first positive indicators, the number of first target leads, and the number of target limb leads; the first positive indicator is used to characterize that the high-frequency morphology index of the corresponding lead is greater than a first threshold; the high-frequency morphology index is the ratio of the first total area to the second total area of ​​the corresponding lead; the first total area is the total area of ​​each amplitude reduction region of the ECG signal in the corresponding resting state; the second total area is the total area under the envelope of the ECG signal in the corresponding resting state; the first target lead is the lead whose total number of times the ECG signal in the corresponding resting state shows a downward trend exceeds the second threshold; the target limb lead is the limb lead whose QRS wave group voltage of the ECG signal in the corresponding resting state is less than the third threshold;

[0010] The risk assessment feature set is evaluated and analyzed to obtain a heart failure risk assessment score; wherein the heart failure risk assessment score is used to determine the magnitude of the risk of heart failure; the risk assessment feature set includes a static high-frequency QRS waveform feature set.

[0011] In one embodiment, the risk assessment feature set also includes a dynamic high-frequency QRS waveform feature set; the method also includes: obtaining the electrocardiogram signal of each lead under the load state; performing data processing on the electrocardiogram signal under each load state to obtain the corresponding high-frequency waveform curve; performing feature analysis on each high-frequency waveform curve to obtain a dynamic high-frequency QRS waveform feature set; wherein the dynamic high-frequency QRS waveform feature set includes at least two of the number of second positive indicators, the initial average voltage value, the maximum output power and the number of second target leads; the second positive indicator is used to characterize that the relative value of the amplitude decrease of the corresponding lead is greater than the fourth threshold value; the relative value of the amplitude decrease It is the ratio of the absolute value of the amplitude to the maximum RMS voltage value; the absolute value of the amplitude is the difference between the maximum RMS voltage value and the target RMS voltage value; the maximum RMS voltage value is the maximum value of the RMS voltage of the corresponding high-frequency waveform curve; the target RMS voltage value is the minimum value of the RMS voltage of the corresponding high-frequency waveform curve after the moment corresponding to the maximum RMS voltage value; the initial average voltage value is the average value of the initial voltage values ​​of each high-frequency waveform curve; the maximum output power is determined according to the maximum value of the root mean square voltage value of each high-frequency waveform curve; the second target lead is the lead whose corresponding high-frequency waveform curve presents the target waveform; the target waveform includes U wave, L wave and small V wave.

[0012] In one embodiment, the step of performing data processing on each resting ECG signal to obtain a static high-frequency QRS waveform feature set includes: performing data extraction on each resting ECG signal to obtain the high-frequency component of the static QRS waveform of the corresponding lead; determining each amplitude reduction area corresponding to each lead based on the high-frequency component of the static QRS waveform of each lead, and calculating the first total area and the corresponding second total area of ​​each lead; obtaining the high-frequency morphology index of each lead based on the ratio of the first total area to the corresponding second total area of ​​each lead; and counting the number of first positive indicators based on the high-frequency morphology index of each lead and a first threshold.

[0013] In one embodiment, after the step of determining each amplitude reduction region corresponding to each lead based on the high-frequency component of the static QRS waveform of each lead, the step further includes: calculating the area of ​​each amplitude reduction region corresponding to each lead; counting the number of target areas of each lead based on the area of ​​each amplitude reduction region corresponding to each lead; the target area refers to the area of ​​the amplitude reduction region that is greater than the fifth threshold; determining the number of target areas of each lead as the total number of corresponding leads; and determining the number of first target leads based on the total number of leads and the second threshold.

[0014] In one embodiment, the step of evaluating and analyzing the risk assessment feature set to obtain a heart failure risk assessment score includes: inputting the risk assessment feature set into a preset risk assessment function or a pre-trained risk assessment network model to obtain a heart failure risk assessment score.

[0015] In one embodiment, the method further includes: determining a heart failure risk level based on a heart failure risk assessment score; and outputting heart failure monitoring warning data in response to the heart failure risk level being greater than a level threshold.

[0016] In a second aspect, an electrocardiogram signal processing device is provided, which includes a signal acquisition module, a signal processing module and an evaluation and analysis module.

[0017] The signal acquisition module is used to acquire electrocardiogram signals of a first preset number of leads in a resting state; the leads include a second preset number of limb leads; and the second preset number is smaller than the first preset number.

[0018] The signal processing module is used to perform data processing on the ECG signals in each resting state to obtain a static high-frequency QRS waveform feature set; wherein, the static high-frequency QRS waveform feature set includes the QRS time limit, the number of first positive indicators, the number of first target leads and the number of target limb leads; the first positive indicator is used to characterize that the high-frequency morphological index of the corresponding lead is greater than the first threshold; the high-frequency morphological index is the ratio of the first total area to the second total area of ​​the corresponding lead; the first total area is the total area of ​​each amplitude reduction area of ​​the ECG signal in the resting state; the second total area is the total area under the envelope of the ECG signal in the resting state; the first target lead is the lead whose total number of times the ECG signal in the resting state shows a downward trend exceeds the second threshold; the target limb lead is the limb lead whose QRS wave group voltage of the ECG signal in the resting state is less than the third threshold.

[0019] The evaluation and analysis module is used to evaluate and analyze the risk assessment feature set to obtain a heart failure risk assessment score; wherein, the heart failure risk assessment score is used to determine the magnitude of the risk of heart failure; the risk assessment feature set includes a static high-frequency QRS waveform feature set.

[0020] In a third aspect, a computer device is provided, which includes a memory and a processor, wherein the memory stores computer-readable instructions, and when the processor executes the computer-readable instructions, the steps of any method in the above method embodiments are implemented.

[0021] In a fourth aspect, an ECG signal processing system is provided, the system comprising an ECG signal acquisition device and a computer device of any one of the above device embodiments; wherein the ECG signal acquisition device is electrically connected to the computer device and is used to acquire ECG signals in various resting states.

[0022] In a fifth aspect, a computer-readable storage medium is provided, on which computer-readable instructions are stored. When the computer-readable instructions are executed by a processor, the steps of any method in the above method embodiments are implemented.

[0023] The details of one or more embodiments of the present application are set forth in the accompanying drawings and the description below. Other features and advantages of the present application will become apparent from the description, drawings, and claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the following briefly introduces the drawings required for use in the embodiments. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.

[0025] FIG1 is a diagram showing an application environment of an electrocardiogram signal processing method according to an embodiment;

[0026] FIG2 is a schematic diagram of a first flow chart of an electrocardiogram signal processing method according to an embodiment;

[0027] FIG3 is a first flow chart illustrating the steps of performing data processing on ECG signals in various resting states to obtain a static high-frequency QRS waveform feature set in one embodiment;

[0028] FIG4 is a second flow chart illustrating the steps of performing data processing on ECG signals in each resting state to obtain a static high-frequency QRS waveform feature set in one embodiment;

[0029] FIG5 is a schematic diagram of a second flow chart of an electrocardiogram signal processing method according to an embodiment;

[0030] FIG6 is a schematic diagram of a third flow chart of an electrocardiogram signal processing method according to an embodiment;

[0031] FIG7 is a schematic diagram of a fourth flow chart of an electrocardiogram signal processing method according to an embodiment;

[0032] FIG8 is a structural block diagram of an electrocardiogram signal processing device according to an embodiment;

[0033] FIG9 is a diagram showing the internal structure of a computer device according to one embodiment;

[0034] FIG10 is a diagram showing the internal structure of an ECG signal processing system according to an embodiment;

[0035] FIG. 11 is a schematic diagram of a region of reduced amplitude according to an embodiment. Implementation Method

[0036] In order to make the technical solutions and advantages of this application more clearly understood, the present application is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain this application and are not intended to limit this application.

[0037] To facilitate understanding of the present application, the present application will be described more fully below with reference to the accompanying drawings. The accompanying drawings provide embodiments of the present application. However, the present application may be implemented in many different forms and is not limited to the embodiments described herein. Rather, these embodiments are provided to make the disclosure of the present application more thorough and comprehensive.

[0038] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application pertains. The terms used herein in the specification of this application are for the purpose of describing specific embodiments only and are not intended to limit this application.

[0039] As used herein, the singular forms "a," "an," and "the" may also include the plural forms, unless the context clearly indicates otherwise. It should also be understood that the terms "include," "comprising," "having," and the like specify the presence of stated features, integers, steps, operations, components, parts, or combinations thereof, but do not preclude the presence or addition of one or more other features, integers, steps, operations, components, parts, or combinations thereof. Furthermore, the term "and / or" as used in this specification includes any and all combinations of the relevant listed items.

[0040] The ECG signal processing method provided herein can be applied in the application environment shown in FIG1 . Terminal 102 communicates with server 104 via a network. Terminal 102 can be, but is not limited to, various personal computers, laptops, smartphones, tablet computers, and portable wearable devices. Server 104 can be implemented as a standalone server or a server cluster consisting of multiple servers.

[0041] In a first aspect, as shown in FIG2 , a method for processing an electrocardiogram signal is provided. The method is described by taking the application of the method to the terminal in FIG1 as an example, and includes the following steps 202 to 206 .

[0042] Step 202: Acquire a first preset number of ECG signals of leads in a resting state.

[0043] The first preset number of leads includes a second preset number of limb leads, where the second preset number is smaller than the first preset number. An ECG signal acquisition device electrically connected to the terminal is configured to acquire ECG signals of the first preset number of leads in a resting state, so that the terminal can obtain the ECG signals of the first preset number of leads in a resting state through the ECG signal acquisition device.

[0044] In one specific example, the first preset number of leads also includes a third preset number of chest leads; the third preset number is the difference between the first preset number and the second preset number. It is understood that the first preset number of leads can be 12 leads, where the 12 leads include 6 chest leads and 6 limb leads; or the first preset number of leads can be 18 leads, where the 18 leads include 12 chest leads and 6 limb leads. The above are merely specific examples; in actual applications, they can be flexibly applied based on user needs and are not limited here.

[0045] Step 204 : Process the ECG signals in each resting state to obtain a static high-frequency QRS waveform feature set.

[0046] The static high-frequency QRS waveform feature set includes QRS duration, the number of first positive indicators, the number of first target leads, and the number of target limb leads.

[0047] Specifically, the QRS duration refers to the time spent between the starting point and the end point of the Q wave, R wave, and S wave in the electrocardiogram generated based on the electrocardiogram signals of each lead in the resting state, and is used to characterize the overall cardiac function status corresponding to the electrocardiogram signals of each lead in the resting state.

[0048] In a specific example, the QRS duration threshold may be, but is not limited to, 0.12 seconds. If the QRS duration is greater than the QRS duration threshold, it indicates that the electrocardiogram generated based on the resting electrocardiogram signals of each lead is abnormal. If the QRS duration is less than or equal to the QRS duration threshold, it indicates that the electrocardiogram generated based on the resting electrocardiogram signals of each lead is normal. The above is only a specific example. In actual applications, it can be flexibly applied according to user needs and is not limited here.

[0049] Specifically, the high-frequency morphology index is the ratio of the first total area and the second total area of ​​the corresponding lead. The first total area is the total area of ​​each amplitude reduction region of the corresponding electrocardiogram signal in the resting state; the second total area is the total area under the envelope of the corresponding electrocardiogram signal in the resting state. The first positive indicator is used to characterize that the high-frequency morphology index of the corresponding lead is greater than the first threshold value, which also indicates that the electrocardiogram signal of the corresponding lead in the resting state is abnormal; conversely, the first negative indicator is used to characterize that the high-frequency morphology index of the corresponding lead is less than or equal to the first threshold value, which also indicates that the electrocardiogram signal of the corresponding lead in the resting state is normal. The number of first positive indicators is used to characterize the overall degree of myocardial ischemia corresponding to the electrocardiogram signal in the resting state of each lead. That is to say, the greater the number of first positive indicators, the greater the risk of myocardial ischemia corresponding to the electrocardiogram signal in the resting state of each lead.

[0050] In a specific example, the first threshold value can be determined according to the age of the ECG signal collector; when the age of the ECG signal collector is greater than 50 years old, the first threshold value can be, but not limited to, 8%; when the age of the ECG signal collector is less than or equal to 50 years old, the first threshold value can be, but not limited to, 15%. The first threshold value can also be the average value of the target high-frequency morphology index or 20% to further improve the accuracy of the heart failure risk assessment score. The target high-frequency morphology index refers to the top three high-frequency morphology indices when the high-frequency morphology indices are sorted in descending order according to their numerical values. The above is only a specific example. In actual applications, it can be flexibly applied according to user needs and is not limited here.

[0051] Specifically, the first target lead is the lead for which the total number of times the corresponding resting ECG signal exhibits a downward trend exceeds a second threshold. That is, if the total number of times the corresponding resting ECG signal exhibits a downward trend exceeds the second threshold, the lead corresponding to the resting ECG signal is determined as the first target lead. The number of first target leads is used to characterize the overall heart failure risk associated with the resting ECG signal for each lead. Furthermore, the presence of a downward trend in the resting ECG signal indicates the presence of a reduced amplitude zone (RAZ) in the QRS waveform of the resting ECG signal. As shown in Figure 11, the reduced amplitude zone refers to the concave region S formed between points A and B in the QRS waveform of the resting ECG signal. In one specific example, by counting the peak-to-peak values ​​of each reduced amplitude zone in the resting ECG signal, the total number of peak-to-peak values ​​of the resting ECG signal can be determined as the total number of times the resting ECG signal exhibits a downward trend. By counting the total number of times the resting ECG signal corresponding to each lead exhibits a downward trend, and comparing the total number of times the resting ECG signal corresponding to each lead exhibits a downward trend with a second threshold, the number of leads whose total number of times the resting ECG signal exhibits a downward trend exceeding the second threshold can be obtained, i.e., the number of first target leads. The above is merely a specific example, and in actual applications, it can be flexibly applied based on user needs and is not limited here.

[0052] Specifically, the target limb lead is the limb lead for which the QRS complex voltage of the corresponding resting ECG signal is less than a third threshold. That is, if the QRS complex voltage of the corresponding resting ECG signal is less than the third threshold, the lead corresponding to the resting ECG signal is determined as the target limb lead. The number of target limb leads is used to indicate the overall risk of worsening heart failure corresponding to the resting ECG signal of each lead.

[0053] In a specific example, the third threshold is determined based on the QRS complex voltage of the electrocardiogram signal corresponding to each chest lead in the resting state. The above is only a specific example, and in actual application, it can be flexibly applied according to user needs and is not limited here.

[0054] It is understandable that by processing the ECG signals in each resting state, a static high-frequency QRS waveform feature set including QRS duration, the number of first positive indicators, the number of first target leads and the number of target limb leads can be obtained.

[0055] In one embodiment, as shown in FIG3 , the step of processing the ECG signals in each resting state to obtain a static high-frequency QRS waveform feature set includes:

[0056] Step 301 : extract data from the ECG signals in each resting state to obtain the high-frequency components of the static QRS waveforms of the corresponding leads.

[0057] Step 302 : determining the amplitude reduction regions corresponding to the respective leads based on the high-frequency components of the static QRS waveforms of the respective leads, and calculating the first total area and the corresponding second total area of ​​the respective leads.

[0058] Step 303: Obtain a high-frequency morphology index of each lead according to the ratio of the first total area of ​​each lead to the corresponding second total area.

[0059] Step 304 : Count the number of first positive indicators based on the high-frequency morphology index of each lead and the first threshold.

[0060] The terminal can extract data from the electrocardiogram signals in each resting state to obtain the high-frequency component of the static QRS waveform of the corresponding lead; then, based on the high-frequency component of the static QRS waveform of each lead, the amplitude reduction area corresponding to each lead can be determined; and, based on the amplitude reduction area corresponding to each lead, the first total area and the corresponding second total area of ​​each lead can be calculated; then, the ratio of the first total area to the corresponding second total area of ​​each lead is calculated to obtain the high-frequency morphological index of each lead; finally, based on the comparison result of the high-frequency morphological index of each lead and the first threshold, the number of first positive indicators can be counted.

[0061] In this embodiment, by extracting data from the ECG signals in each resting state, the high-frequency components of the static QRS waveform of the corresponding lead are obtained. The accurate number of first positive indicators can be obtained through the high-frequency components of the static QRS waveform of each lead. Therefore, the number of first positive indicators can be used to understand the number of leads in which the ECG signals in the resting state of the corresponding lead are abnormal, which facilitates obtaining the risk assessment feature set and the heart failure risk assessment score.

[0062] In one embodiment, as shown in FIG4 , after the step of determining the amplitude reduction region corresponding to each lead according to the high frequency component of the static QRS waveform of each lead, the following steps are further included:

[0063] Step 401: Calculate the area of ​​each amplitude reduction region corresponding to each lead.

[0064] Step 402 : Count the number of target areas of each lead according to the area of ​​each amplitude reduction region corresponding to each lead.

[0065] Step 403: Determine the number of target areas for each lead as the total number of times for the corresponding lead.

[0066] Step 404: Determine the number of first target leads according to the total number of leads and the second threshold.

[0067] The target area refers to the area of ​​the amplitude reduction region that is greater than the fifth threshold. The terminal determines the amplitude reduction regions corresponding to each lead based on the high-frequency components of the static QRS waveform of each lead, thereby calculating the area of ​​each amplitude reduction region corresponding to each lead. The area of ​​the amplitude reduction region that is greater than the fifth threshold is determined as the target area. The number of target areas for each lead is then calculated based on the area of ​​each amplitude reduction region corresponding to each lead. Furthermore, the number of target areas for each lead is determined as the total number of times the ECG signal in the resting state of the corresponding lead exhibits a downward trend. Finally, the number of first target leads is determined based on the comparison of the total number of times for each lead with the second threshold.

[0068] In this embodiment, the area of ​​each amplitude reduction region corresponding to each lead is used to count the number of target areas of each lead, thereby accurately obtaining the total number of times the electrocardiogram signal in each resting state shows a downward trend, and then determining the number of first target leads, thereby improving the convenience of obtaining a risk assessment feature set and thus a heart failure risk assessment score.

[0069] Step 206: Evaluate and analyze the risk assessment feature set to obtain a heart failure risk assessment score.

[0070] The heart failure risk assessment score is used to determine the risk of heart failure. The risk assessment feature set includes a static high-frequency QRS waveform feature set. The terminal evaluates and analyzes the risk assessment feature set to obtain a heart failure risk assessment score, providing an accurate understanding of the risk of heart failure.

[0071] Based on this, the above-mentioned ECG signal processing method obtains the ECG signals of a first preset number of leads in a resting state; then, based on the data processing of each ECG signal in the resting state, a static high-frequency QRS waveform feature set is obtained; then, the risk assessment feature set is evaluated and analyzed to obtain a heart failure risk assessment score, thereby accurately understanding the magnitude of the risk of heart failure. In addition, by obtaining a complete and comprehensive static high-frequency QRS waveform feature set and risk assessment feature set after processing the ECG signal, the magnitude of the risk of heart failure can be directly understood through the heart failure risk assessment score, thereby avoiding the need for multiple test data to be combined for heart failure risk assessment in traditional methods, reducing the time consumption of heart failure risk assessment, and improving the efficiency of heart failure risk assessment.

[0072] In one embodiment, as shown in FIG5 , the risk assessment feature set further includes a dynamic high-frequency QRS waveform feature set. The above method further includes:

[0073] Step 501: Acquire the ECG signal of each lead under load status.

[0074] Step 502 : Process the ECG signals under each load state to obtain corresponding high-frequency waveform curves.

[0075] Step 503: Perform feature analysis on each high-frequency waveform curve to obtain a dynamic high-frequency QRS waveform feature set.

[0076] ECG signals under load include ECG signals in a resting state, an exercise state, and a recovery state. ECG signals under load for a first preset number of leads are collected by configuring an ECG signal acquisition device electrically connected to the terminal. The terminal can obtain the ECG signals under load for each lead through the ECG signal acquisition device. Data processing is then performed on the ECG signals under load for each lead to obtain a corresponding high-frequency waveform curve. Feature analysis is then performed on each high-frequency waveform curve to obtain a dynamic high-frequency QRS waveform feature set.

[0077] In a specific example, the steps of performing feature analysis on each high-frequency waveform curve to obtain a dynamic high-frequency QRS waveform feature set include: extracting feature points from each high-frequency waveform curve to obtain corresponding target feature points; and extracting features based on the corresponding target feature points to obtain a dynamic high-frequency QRS waveform feature set. The above is merely a specific example, and in actual applications, it can be flexibly applied according to user needs and is not limited here.

[0078] Specifically, the dynamic high-frequency QRS waveform feature set includes at least two of the following: the number of second positive indicators, the initial average voltage value, the maximum output power, and the number of second target leads. It is understood that the more features in the dynamic high-frequency QRS waveform feature set, the more comprehensive the data used to evaluate and analyze the risk assessment feature set and the more accurate the heart failure risk assessment score.

[0079] The relative value of the amplitude drop is the ratio of the absolute value of the amplitude to the maximum RMS voltage value; the absolute value of the amplitude is the difference between the maximum RMS voltage value and the target RMS voltage value; the maximum RMS voltage value is the maximum value of the RMS voltage of the corresponding high-frequency waveform curve; and the target RMS voltage value is the minimum value of the RMS voltage of the corresponding high-frequency waveform curve after the moment corresponding to the maximum RMS voltage value. It can be understood that a positive second indicator means that the relative value of the amplitude drop of the corresponding lead is greater than the fourth threshold; conversely, a negative second indicator means that the relative value of the amplitude drop of the corresponding lead is less than or equal to the fourth threshold. The number of positive second indicators is used to characterize the overall degree of myocardial ischemia corresponding to the electrocardiogram signal under load in each lead. In other words, the greater the number of positive second indicators, the greater the risk of myocardial ischemia.

[0080] Specifically, the initial average voltage value is the average of the initial voltage values ​​of each high-frequency waveform curve, and is used to indicate whether the overall cardiac pumping function corresponding to the ECG signal under load in each lead is abnormal. The initial voltage value refers to the voltage value at the initial moment of the high-frequency waveform curve. The maximum output power is determined based on the maximum root mean square voltage value of each high-frequency waveform curve, and is used to indicate the overall cardiac pumping capacity corresponding to the ECG signal under load in each lead.

[0081] The second target lead is the lead whose corresponding high-frequency waveform curve presents a target waveform; the target waveform includes the U wave, L wave, and small V wave. The number of second target leads is used to represent the severity of coronary artery stenosis corresponding to the ECG signal under the load state of each lead.

[0082] In this embodiment, the ECG signals of each lead under the load state are obtained; then, the ECG signals under each load state are data processed to obtain the corresponding high-frequency waveform curves; then, the characteristics of each high-frequency waveform curve are analyzed to obtain the dynamic high-frequency QRS waveform feature set, thereby realizing the evaluation and analysis combined with the static high-frequency QRS waveform feature set and the dynamic high-frequency QRS waveform feature set, so as to obtain a more accurate heart failure risk assessment score through the ECG signals of each lead under the resting state and the load state, thereby further improving the accuracy and convenience of heart failure risk assessment.

[0083] In one embodiment, as shown in FIG6 , the step of evaluating and analyzing the risk assessment feature set to obtain a heart failure risk assessment score includes step 601 .

[0084] Step 601: Input the risk assessment feature set into a preset risk assessment function or a pre-trained risk assessment network model to obtain a heart failure risk assessment score.

[0085] The terminal can pre-store a preset risk assessment function or a pre-trained risk assessment network model, and input the risk assessment feature set into the preset risk assessment function to output the corresponding heart failure risk assessment score through the risk assessment function, and / or input the risk assessment feature set into the pre-trained risk assessment network model to output the corresponding heart failure risk assessment score through the risk assessment network model.

[0086] In a specific example, the first heart failure risk assessment sub-score is obtained based on the following expression:

[0087]

[0088] It is the first heart failure risk assessment subscore; is the QRS duration.

[0089] The second heart failure risk assessment subscore was obtained based on the following expression:

[0090]

[0091] A subscore was used to assess the risk of secondary heart failure; is the number of first positive indicators.

[0092] The third heart failure risk assessment subscore was obtained based on the following expression:

[0093]

[0094] The third heart failure risk assessment subscore; is the number of the first target lead.

[0095] The fourth heart failure risk assessment subscore was obtained based on the following expression:

[0096]

[0097] The fourth heart failure risk assessment subscore; is the number of target limb leads.

[0098] The fifth heart failure risk assessment subscore was obtained based on the following expression:

[0099]

[0100] The fifth heart failure risk assessment subscore; is the number of positive results for the second indicator;

[0101] The sixth heart failure risk assessment sub-score was obtained based on the following expression.

[0102]

[0103] The sixth heart failure risk assessment subscore; is the initial average voltage value.

[0104] The seventh heart failure risk assessment subscore was obtained based on the following expression:

[0105]

[0106] The seventh heart failure risk assessment subscore; is the maximum output power.

[0107] The eighth heart failure risk assessment subscore is obtained based on the following expression:

[0108]

[0109] The eighth heart failure risk assessment subscore; is the number of the second target lead;

[0110] The heart failure risk assessment score is obtained based on the expression of the following risk assessment function:

[0111]

[0112] is the heart failure risk assessment score; It is the first heart failure risk assessment subscore; A subscore was used to assess the risk of secondary heart failure; The third heart failure risk assessment subscore; The fourth heart failure risk assessment subscore; The fifth heart failure risk assessment subscore; The sixth heart failure risk assessment subscore; The seventh heart failure risk assessment subscore; is the eighth heart failure risk assessment sub-score; the above is only a specific example, and in actual application, it can be flexibly applied according to user needs and is not limited here.

[0113] In a specific example, the eighth heart failure risk assessment sub-score can also be obtained based on the following expression:

[0114]

[0115] The eighth heart failure risk assessment subscore; is the number of the second target lead; is the number of the third target lead; The number of the fourth target lead is defined as the number of the fourth target lead. The third target lead is the second target lead whose minimum RMS voltage on the high-frequency waveform curve is within the target time. The target time is from the start of the ECG signal during exercise to the preset time. It is understood that the fourth target lead is the second target lead whose minimum RMS voltage on the high-frequency waveform curve is not within the target time. Furthermore, the preset time can be, but is not limited to, 180 seconds. This can be flexibly set based on user needs in actual applications and is not a limitation here.

[0116] In one embodiment, as shown in FIG7 , the method further includes step 701 and step 702 .

[0117] Step 701: Determine the heart failure risk level according to the heart failure risk assessment score.

[0118] Step 702: In response to the heart failure risk level being greater than the level threshold, outputting heart failure monitoring warning data.

[0119] The terminal evaluates and analyzes the risk assessment feature set to obtain a heart failure risk assessment score; then, determines the heart failure risk level based on the heart failure risk assessment score; then, in response to the heart failure risk level being greater than the level threshold, outputs heart failure monitoring warning data.

[0120] In this embodiment, the heart failure risk level is determined based on the heart failure risk assessment score; then, in response to the heart failure risk level being greater than the level threshold, heart failure monitoring and early warning data is output, so that the ECG signal collector can understand his or her own heart failure risk in a timely manner, thereby improving the convenience of the ECG signal processing method.

[0121] In one embodiment, the step of determining the heart failure risk level according to the heart failure risk assessment score includes: determining the heart failure risk level according to the interval in which the heart failure risk assessment score falls.

[0122] The above intervals include a first preset scoring interval, a second preset scoring interval, and a third preset scoring interval. The upper limit of the first preset scoring interval is less than or equal to the lower limit of the second preset scoring interval, and the upper limit of the second preset scoring interval is less than or equal to the lower limit of the third preset scoring interval.

[0123] The heart failure risk levels include the first level, the second level, and the third level. If the heart failure risk assessment score of the terminal falls within the first preset scoring interval, the heart failure risk level is determined to be the first level. The first level indicates that the heart failure risk of the ECG signal collector is small, and rehabilitation exercise treatment is effective, or the intensity of the rehabilitation exercise treatment program can be reduced. If the heart failure risk assessment score of the terminal falls within the second preset scoring interval, the heart failure risk level is determined to be the second level. The second level indicates that the heart failure risk of the ECG signal collector is moderate, and rehabilitation exercise treatment can be continued. The intensity of the rehabilitation exercise treatment program needs to wait until the heart failure risk assessment score falls within the first preset scoring interval. If the heart failure risk assessment score of the terminal falls within the third preset scoring interval, the heart failure risk level is determined to be the third level. The third level indicates that the heart failure risk of the ECG signal collector is serious, and the rehabilitation exercise treatment effect is poor, or the intensity of the rehabilitation exercise treatment program is temporarily reduced and gradually increased after adaptation.

[0124] In this embodiment, the heart failure risk level is determined according to the interval of the heart failure risk assessment score, so that the heart failure risk level of the ECG signal collector can be accurately determined, which facilitates understanding the effect of rehabilitation exercise treatment and adjusting the intensity of the rehabilitation exercise treatment plan.

[0125] It should be understood that, although the various steps in the flowcharts of Figures 2-7 are shown in sequence as indicated by the arrows, these steps are not necessarily performed in the order indicated by the arrows. Unless otherwise specified herein, there is no strict order restriction on the execution of these steps, and these steps can be performed in other orders. Moreover, at least a portion of the steps in Figures 2-7 may include multiple sub-steps or multiple stages, and these sub-steps or stages are not necessarily performed at the same time, but can be performed at different times. The execution order of these sub-steps or stages is not necessarily to be performed in sequence, but can be performed in turn or alternately with other steps or at least a portion of the sub-steps or stages of other steps.

[0126] In one embodiment, as shown in FIG8 , an electrocardiogram signal processing device is provided. The device includes a signal acquisition module 810 , a signal processing module 820 , and an evaluation and analysis module 830 .

[0127] The signal acquisition module 810 is used to acquire a first preset number of leads of the electrocardiogram signal in a resting state; the leads include a second preset number of limb leads; and the second preset number is smaller than the first preset number.

[0128] The signal processing module 820 is used to perform data processing on the ECG signals in each resting state to obtain a static high-frequency QRS waveform feature set; the static high-frequency QRS waveform feature set includes the QRS time limit, the number of first positive indicators, the number of first target leads and the number of target limb leads; the first positive indicator is used to characterize that the high-frequency morphology index of the corresponding lead is greater than the first threshold; the high-frequency morphology index is the ratio of the first total area to the second total area of ​​the corresponding lead; the first total area is the total area of ​​each amplitude reduction region of the ECG signal in the corresponding resting state; the second total area is the total area under the envelope of the ECG signal in the corresponding resting state; the first target lead is the lead whose total number of times the ECG signal in the corresponding resting state shows a downward trend exceeds the second threshold; the target limb lead is the limb lead whose QRS wave group voltage of the ECG signal in the corresponding resting state is less than the third threshold.

[0129] The evaluation and analysis module 830 is used to evaluate and analyze the risk assessment feature set to obtain a heart failure risk assessment score; the heart failure risk assessment score is used to determine the magnitude of the risk of heart failure; the risk assessment feature set includes a static high-frequency QRS waveform feature set.

[0130] In one embodiment, the risk assessment feature set further includes a dynamic high-frequency QRS waveform feature set; the signal acquisition module 810 is further configured to acquire the electrocardiogram signal of each lead under load. The signal processing module 820 is also used to perform data processing on the ECG signals under each load state to obtain the corresponding high-frequency waveform curve; the signal processing module 820 is also used to perform feature analysis on each high-frequency waveform curve to obtain a dynamic high-frequency QRS waveform feature set; the dynamic high-frequency QRS waveform feature set includes the number of second positive indicators, the initial average voltage value, the maximum output power and the number of second target leads; the second positive indicator is used to characterize that the relative value of the amplitude decrease of the corresponding lead is greater than the fourth threshold; the relative value of the amplitude decrease is the ratio of the absolute value of the amplitude to the maximum RMS voltage value; the absolute value of the amplitude is the difference between the maximum RMS voltage value and the target RMS voltage value; the maximum RMS voltage value is the maximum value of the RMS voltage of the corresponding high-frequency waveform curve; the target RMS voltage value is the minimum value of the RMS voltage of the corresponding high-frequency waveform curve after the moment corresponding to the maximum RMS voltage value; the initial average voltage value is the average value of the initial voltage values ​​of each high-frequency waveform curve; the maximum output power is determined based on the maximum root mean square voltage value of each high-frequency waveform curve; the second target lead is the lead whose corresponding high-frequency waveform curve presents a target waveform; the target waveform includes U wave, L wave and small V wave.

[0131] In one embodiment, the signal processing module 820 includes a signal processing unit: the signal processing unit is used to extract data from the electrocardiogram signals in each resting state to obtain the high-frequency component of the static QRS waveform of the corresponding lead; the signal processing unit is also used to determine the amplitude reduction areas corresponding to each lead based on the high-frequency component of the static QRS waveform of each lead, and calculate the first total area and the corresponding second total area of ​​each lead; the signal processing unit is also used to obtain the high-frequency morphology index of each lead based on the ratio of the first total area of ​​each lead to the corresponding second total area; the signal processing unit is also used to count the number of first positive indicators based on the high-frequency morphology index of each lead and the first threshold.

[0132] In one embodiment, the signal processing unit is further used to calculate the area of ​​each amplitude reduction region corresponding to each lead; the signal processing unit is further used to count the number of target areas of each lead based on the area of ​​each amplitude reduction region corresponding to each lead; the signal processing unit is further used to determine that the target area refers to the area of ​​the amplitude reduction region that is greater than a fifth threshold; the signal processing unit is further used to determine the number of target areas of each lead as the total number of corresponding leads; the signal processing unit is further used to determine the number of first target leads based on the total number of leads and the second threshold.

[0133] In one embodiment, the assessment and analysis module 830 includes an assessment and analysis unit configured to input the risk assessment feature set into a preset risk assessment function or a pre-trained risk assessment network model to obtain a heart failure risk assessment score.

[0134] In one embodiment, the above-mentioned device further includes a risk grading module and a risk early warning module.

[0135] The risk grading module is used to determine the heart failure risk level based on the heart failure risk assessment score; the risk warning module is used to output heart failure monitoring warning data in response to the heart failure risk level being greater than the level threshold.

[0136] For specific definitions of the ECG signal processing device, please refer to the definitions of the ECG signal processing method above and will not be repeated here. The various modules in the above-mentioned ECG signal processing device can be implemented in whole or in part through software, hardware, or a combination thereof. The above-mentioned modules can be embedded in or independent of the processor in the computer device in hardware form, or can be stored in the memory of the computer device in software form, so that the processor can call and execute the corresponding operations of the above modules.

[0137] In one embodiment, a computer device 900 is provided. This computer device 900 may be a terminal, and its internal structure may be as shown in FIG9 . The computer device 900 includes a processor, memory, a network interface, a display screen, and an input device connected via a system bus. The processor of the computer device 900 provides computing and control capabilities. The memory of the computer device 900 includes a non-volatile storage medium and internal memory. The non-volatile storage medium stores an operating system and computer-readable instructions. The internal memory provides an environment for the operation of the operating system and computer-readable instructions in the non-volatile storage medium. The network interface of the computer device 900 communicates with an external terminal via a network connection. When executed by the processor, the computer-readable instructions implement a method for processing electrocardiogram signals. The display screen of the computer device 900 may be a liquid crystal display or an electronic ink display. The input device of the computer device 900 may be a touchscreen covering the display screen, keys, a trackball, or a touchpad provided on the housing of the computer device 900, or an external keyboard, touchpad, or mouse.

[0138] Those skilled in the art will understand that the structure shown in FIG9 is merely a block diagram of a portion of the structure related to the solution of the present application, and does not constitute a limitation on the computer device 900 to which the solution of the present application is applied. The specific computer device 900 may include more or fewer components than shown in the figure, or combine certain components, or have a different component arrangement.

[0139] In a third aspect, a computer device 900 is provided. The storage device includes a memory and a processor. The memory stores computer-readable instructions. When the processor executes the computer-readable instructions, the steps of any method in the above method embodiments are implemented.

[0140] In a fourth aspect, an electrocardiogram signal processing system is provided. As shown in FIG10 , the system includes an electrocardiogram signal acquisition device 1010 and a computer device 900 according to any one of the above device embodiments.

[0141] The ECG signal acquisition device 1010 is electrically connected to the computer device 900 and is used to acquire ECG signals in various resting states.

[0142] In this embodiment, the heart failure risk assessment system described above can directly generate a heart failure risk assessment score, providing an accurate understanding of the magnitude of the heart failure risk. Furthermore, directly determining the magnitude of the heart failure risk using the heart failure risk assessment score avoids the traditional method of combining multiple test data for heart failure risk assessment, reducing the time required for heart failure risk assessment and improving its efficiency.

[0143] In one embodiment, the ECG signal acquisition device 1010 is further configured to acquire ECG signals under various load conditions.

[0144] In a fifth aspect, a computer-readable storage medium is provided, on which computer-readable instructions are stored. When the computer-readable instructions are executed by a processor, the steps of any method in the above method embodiments are implemented.

[0145] Those skilled in the art will understand that all or part of the processes in the above-mentioned embodiment methods can be implemented by instructing related hardware through computer-readable instructions. The computer-readable instructions can be stored in a non-volatile computer-readable storage medium. When the computer-readable instructions are executed, they can include the processes of the embodiments of the above-mentioned methods. Any reference to memory, storage, database or other media used in the embodiments provided in this application may include non-volatile and / or volatile memory. Non-volatile memory may include read-only memory (ROM), programmable ROM (PROM), electrically programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM) or flash memory. Volatile memory may include random access memory (RAM) or external cache memory. By way of illustration and not limitation, RAM is available in many forms such as static RAM (SRAM), dynamic RAM (DRAM), synchronous DRAM (SDRAM), double data rate SDRAM (DDRSDRAM), enhanced SDRAM (ESDRAM), Synchronous Link DRAM (SLDRAM), Rambus direct RAM (RDRAM), direct memory bus dynamic RAM (DRDRAM), and memory bus dynamic RAM (RDRAM), etc.

[0146] The technical features of the above embodiments can be combined arbitrarily. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0147] The above-described embodiments merely represent several implementation methods of the present application. While the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the present invention. It should be noted that a person skilled in the art could make various modifications and improvements without departing from the spirit of the present application, all of which fall within the scope of protection of the present application. Therefore, the scope of protection of the present patent application shall be determined by the appended claims.

Claims

1. A method for processing an electrocardiogram signal, characterized in that: The method comprises: Acquiring a first preset number of leads of electrocardiographic signals in a resting state; the leads include a second preset number of limb leads; the second preset number is smaller than the first preset number; Data processing is performed on each of the resting ECG signals to obtain a static high-frequency QRS waveform feature set; wherein the static high-frequency QRS waveform feature set includes QRS duration, the number of first positive indicators, the number of first target leads, and the number of target limb leads; the first positive indicator is used to characterize that the high-frequency morphology index corresponding to the lead is greater than a first threshold; the high-frequency morphology index is the ratio of the first total area and the second total area corresponding to the lead; the first total area is the total area of ​​each amplitude reduction region corresponding to the resting ECG signal; the second total area is the total area under the envelope of the resting ECG signal; the first target lead is the lead whose total number of times the resting ECG signal shows a downward trend exceeds a second threshold; the target limb lead is the limb lead whose QRS complex voltage of the resting ECG signal is less than a third threshold; Evaluating and analyzing the risk assessment feature set to obtain a heart failure risk assessment score; wherein the heart failure risk assessment score is used to determine the magnitude of the risk of heart failure; the risk assessment feature set includes the static high-frequency QRS waveform feature set; The step of performing data processing on each of the resting electrocardiogram signals to obtain a static high-frequency QRS waveform feature set includes: Extracting data from the electrocardiogram signals in the resting state to obtain high-frequency components of the static QRS waveform corresponding to the lead; determining each of the amplitude reduction regions corresponding to each of the leads according to the high-frequency components of the static QRS waveform of each of the leads, and calculating the first total area and the corresponding second total area of ​​each of the leads; Obtaining the high-frequency morphology index of each lead according to a ratio of the first total area of ​​each lead to the corresponding second total area; counting the number of the first positive indicators according to the high-frequency morphology index of each lead and the first threshold; Calculating the area of ​​each of the amplitude reduction regions corresponding to each of the leads; counting the number of target areas of each lead according to the area of ​​each amplitude reduction region corresponding to each lead; the target area refers to the area of ​​the amplitude reduction region that is greater than a fifth threshold; determining the number of the target areas of each of the leads as the total number of times corresponding to the lead; The number of the first target leads is determined according to the total number of times of each lead and the second threshold.

2. The method according to claim 1, characterized in that The risk assessment feature set also includes a dynamic high-frequency QRS waveform feature set; the method further includes: Acquiring an electrocardiogram signal of each lead under a load state; Performing data processing on the electrocardiogram signals under each of the load states to obtain corresponding high-frequency waveform curves; A feature analysis is performed on each of the high-frequency waveform curves to obtain the dynamic high-frequency QRS waveform feature set; wherein the dynamic high-frequency QRS waveform feature set includes at least two of the number of second positive indicators, the initial average voltage value, the maximum output power, and the number of second target leads; the second positive indicator is used to characterize that the relative value of the amplitude decrease of the corresponding lead is greater than a fourth threshold; the relative value of the amplitude decrease is the ratio of the absolute value of the amplitude to the maximum RMS voltage value; the absolute value of the amplitude is the difference between the maximum RMS voltage value and the target RMS voltage value; the maximum RMS voltage value is the maximum value of the RMS voltage of the corresponding high-frequency waveform curve; the target RMS voltage value is the minimum value of the RMS voltage of the corresponding high-frequency waveform curve after the moment corresponding to the maximum RMS voltage value; the initial average voltage value is the average value of the initial voltage values ​​of each of the high-frequency waveform curves; the maximum output power is determined based on the maximum root mean square voltage value of each of the high-frequency waveform curves; the second target lead is the lead corresponding to the high-frequency waveform curve presenting a target waveform; the target waveform includes a U wave, an L wave, and a small V wave.

3. The method according to any one of claims 1 to 2, characterized in that The step of evaluating and analyzing the risk assessment feature set to obtain a heart failure risk assessment score comprises: The risk assessment feature set is input into a preset risk assessment function or a pre-trained risk assessment network model to obtain the heart failure risk assessment score.

4. The method according to any one of claims 1 to 2, characterized in that The method further comprises: determining a heart failure risk level according to the heart failure risk assessment score; In response to the heart failure risk level being greater than the level threshold, heart failure monitoring warning data is output.

5. An electrocardiogram signal processing device, characterized in that: The device comprises: A signal acquisition module, configured to acquire a first preset number of leads of electrocardiographic signals in a resting state; the leads include a second preset number of limb leads; the second preset number is smaller than the first preset number; A signal processing module is used to perform data processing on each of the electrocardiogram signals in the resting state to obtain a static high-frequency QRS waveform feature set; wherein the static high-frequency QRS waveform feature set includes QRS duration, the number of first positive indicators, the number of first target leads and the number of target limb leads; the first positive indicator is used to characterize that the high-frequency morphology index corresponding to the lead is greater than a first threshold; the high-frequency morphology index is the ratio of the first total area and the second total area corresponding to the lead; the first total area is the total area of ​​each amplitude reduction region corresponding to the electrocardiogram signal in the resting state; the second total area is the total area under the envelope of the electrocardiogram signal in the resting state; the first target lead is the lead whose total number of times the electrocardiogram signal in the resting state shows a downward trend exceeds the second threshold; the target limb lead is the limb lead whose QRS wave group voltage of the electrocardiogram signal in the resting state is less than a third threshold; An evaluation and analysis module is used to evaluate and analyze the risk assessment feature set to obtain a heart failure risk assessment score; wherein the heart failure risk assessment score is used to determine the magnitude of the risk of heart failure; the risk assessment feature set includes the static high-frequency QRS waveform feature set; Wherein, the signal processing module includes a signal processing unit: the signal processing unit is used to extract data from the electrocardiogram signals in the resting state to obtain the high-frequency component of the static QRS waveform corresponding to the lead; the signal processing unit is also used to determine the amplitude reduction area corresponding to each lead according to the high-frequency component of the static QRS waveform of each lead, and calculate the first total area and the corresponding second total area of ​​each lead; the signal processing unit is also used to obtain the high-frequency morphological index of each lead according to the ratio of the first total area to the corresponding second total area of ​​each lead; the signal processing unit is also used to obtain the high-frequency morphological index of each lead according to the ratio of the first total area to the corresponding second total area of ​​each lead. The high-frequency morphology index and the first threshold are used to count the number of the first positive indicators; the signal processing unit is also used to calculate the area of ​​each of the amplitude reduction regions corresponding to each of the leads; the signal processing unit is also used to count the number of target areas of each of the leads based on the area of ​​each of the amplitude reduction regions corresponding to each of the leads; the target area refers to the area of ​​the amplitude reduction region that is greater than the fifth threshold; the signal processing unit is also used to determine the number of the target areas of each of the leads as the total number of times corresponding to the lead; the signal processing unit is also used to determine the number of the first target leads based on the total number of times of each of the leads and the second threshold.

6. The device according to claim 5, characterized in that The risk assessment feature set also includes a dynamic high-frequency QRS waveform feature set; the signal acquisition module is also used to obtain the electrocardiogram signal of each lead under the load state; the signal processing module is also used to perform data processing on the electrocardiogram signal under each load state to obtain the corresponding high-frequency waveform curve; perform feature analysis on each high-frequency waveform curve to obtain the dynamic high-frequency QRS waveform feature set; wherein, the dynamic high-frequency QRS waveform feature set includes at least two of the number of second positive indicators, the initial average voltage value, the maximum output power and the number of second target leads; the second positive indicator is used to characterize that the relative value of the amplitude decrease of the corresponding lead is greater than the fourth threshold value; the relative value of the amplitude decrease is the amplitude The absolute value is the ratio of the maximum RMS voltage value to the maximum RMS voltage value; the absolute value of the amplitude is the difference between the maximum RMS voltage value and the target RMS voltage value; the maximum RMS voltage value is the maximum value of the RMS voltage corresponding to the high-frequency waveform curve; the target RMS voltage value is the minimum value of the RMS voltage corresponding to the high-frequency waveform curve after the moment corresponding to the maximum RMS voltage value; the initial average voltage value is the average value of the initial voltage values ​​of each high-frequency waveform curve; the maximum output power is determined according to the maximum value of the root mean square voltage value of each high-frequency waveform curve; the second target lead is the lead corresponding to the high-frequency waveform curve presenting a target waveform; the target waveform includes U wave, L wave and small V wave.

7. The device according to any one of claims 5 to 6, characterized in that The evaluation and analysis module includes an evaluation and analysis unit; the evaluation and analysis unit is used to input the risk assessment feature set into a preset risk assessment function or a pre-trained risk assessment network model to obtain the heart failure risk assessment score.

8. The device according to any one of claims 5 to 6, characterized in that It also includes risk rating module and risk early warning module; The risk grading module is configured to determine the heart failure risk grade according to the heart failure risk assessment score; The risk warning module is configured to output heart failure monitoring warning data in response to the heart failure risk level being greater than a level threshold.

9. A computer device comprising a memory, a processor, and computer-readable instructions stored in the memory and executable on the processor, wherein: When the processor executes the computer-readable instructions, the steps of the method according to any one of claims 1 to 4 are implemented.

10. An electrocardiogram signal processing system, characterized in that: The system includes an electrocardiogram signal acquisition device and the computer device according to claim 9; wherein the electrocardiogram signal acquisition device is electrically connected to the computer device and is used to acquire the electrocardiogram signals in each of the resting states.

11. A computer-readable storage medium having computer-readable instructions stored thereon, characterized in that: When the computer-readable instructions are executed by a processor, the steps of the method according to any one of claims 1 to 4 are implemented.